Interleukin (IL)-4 induces production of cytokine-induced neutrophil chemoattractants (CINCs) and intercellular adhesion molecule (ICAM)-1 in lungs of asthmatic rats

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 4, 2013, Pages 470-478

  Guo, Ya Li ^a,d   Huang, Hong ^a   Zeng, Da Xiong ^b   Zhao, Jian Ping ^a   Fang, Hui Juan ^a   Lavoie, Jean Pierre ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

cytokine induced neutrophil chemoattractants; intercellular adhesion molecule 1; interleukin 4; rat

Indexed keywords

CHEMOTACTIC FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4;

ANIMAL; ARTICLE; ASTHMA; IMMUNOLOGY; LUNG; MALE; NEUTROPHIL; RAT; WISTAR RAT;

ANIMALS; ASTHMA; CHEMOTACTIC FACTORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-4; LUNG; MALE; NEUTROPHILS; RATS; RATS, WISTAR;

EID: 84881303388     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1144-5     Document Type: Article

References (61)

1. Kon OM, Kay AB. T cells and chronic asthma. Int Arch Allergy Immunol, 1999,118(2-4):133-135
2. Kay AB. T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol, 1991,94(1-4):189-193
3. Taube C, Dakhama A, Gelfand EW. Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allerg Immun, 2004,135(2):173-186
4. Chatila TA. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med, 2004,10(10):493-499
5. Sur S, Crotty TB, Kephart GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis, 1993,148(3):713-719
6. Norzila MZ, Fakes K, Henry RL, et al. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med, 2000,161(3 Pt 1):769-774
7. Fahy JV, Kim KW, Liu J, et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol, 1995,95(4):843-852
8. Lamblin C, Gosset P, Tillie-Leblond I, et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med, 1998,157(2):394-402
9. Turner MO, Hussack P, Sears MR, et al. Exacerbations of asthma without sputum eosinophilia. Thorax, 1995,50(10):1057-1061
10. Mukaida N, Harada A, Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev, 1998,9(1):9-23
11. Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev, 2000,52(3):349-374
12. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol, 2005,7(2):122-133
13. Li A, Dubey S, Varney ML, et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol, 2003,170(6):3369-3376
14. Lee KS, Jin SM, Kim HJ, et al. Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol, 2003,111(6):1278-1284
15. Gueders MM, Balbin M, Rocks N, et al. Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J Immunol, 2005,175(4):2589-2597
16. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci, 2002,3(4):409-421
17. Suzuki R, Miyazaki Y, Takagi K, et al. Matrix metalloproteinases in the pathogenesis of asthma and COPD: Implications for therapy. Treat Respir Med, 2004,3(1):17-27
18. Nishina K. Expression of CINC-2 is related to the state of differentiation of alveolar epithelial cells. Am J Respir Cell Mol Biol, 2005,33(5):505-512
19. Shibata F, Kato H, Konishi K, et al. Differential changes in the concentrations of cytokine induced neutrophil chemoattractant (CINC)-1 and CINC-2 in exudate during rat lipopolysaccharide-induced inflammation. Cytokine, 1996,8(3):222-226
20. Shibata F. Identification of a common receptor for three types of rat cytokine-induced neutrophil chemoattractants (CINCs). Cytokine, 2000,12(9):1368-1373
21. Green CE, Pearson DN, Camphausen RT, et al. Shear-dependent capping of L-selectin and P-selectin glycoprotein ligand 1 by E-selectin signals activation of high-avidity beta2-integrin on neutrophils. J Immunol, 2004,172(12):7780- 7790
22. McEver RP, Zhu C. A catch to integrin activation. Nat Immunol, 2007,8(10):1035-1037
23. Chan SC, Shum DK, Tipoe GL, et al. Upregulation of ICAM-1 expression in bronchial epithelial cells by airway secretions in bronchiectasis. Respir Med, 2008,102(2):287-298
24. Striz I, Mio T, Adachi Y, et al. IL-4 induces ICAM-1 expression in human bronchial epithelial cells and potentiates TNF-alpha. Am J Physiol, 1999,277(1 Pt 1):L58-L64
25. Huang H, Lavoie-Lamoureux A, Moran K, et al. IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol, 2007,292(5):L1147-L1154
26. Yang DF, Huang H, Guan S, et al. Interleukin(IL)-4 promotion of CXCL-8 gene transcription is mediated by ERK1/2 pathway in human pulmonary artery endothelial cells. Mol Immunol, 2011,48(15-16):1784-1792
27. Zhang C, Ge CL, Guo RX, et al. Effect of IL-4 on altered expression of complement activation regulators in rat pancreatic cells during severe acute pancreatitis. World J Gastroenterol, 2005,11(43):6770-6774
28. Ratthé C, Ennaciri J, Garcês Gonçalves DM, et al. Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism. Mediators Inflamm, 2009,2009:1-10
29. Kang JL, Lee HW, Lee HS, et al. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. Am J Respir Crit Care Med, 2001,164(12):2206-2212
30. Rabb HA, Olivenstein R, Issekutz TB, et al. The role of the leukocyte adhesion molecules VLA-4, LFA-1, and MAC-1 in allergic airway responses in the rat. Am J Respir Crit Care Med, 1994,149(5):1186-1191
31. Livak K Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001,25(4):402-408
32. Niiro H, Otsuka T, Izuhara K, et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood, 1997,89(5):1621-1628
33. Marie C, Pitton C, Fitting C, et al. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. Cytokine, 1996,8(2):147-151
34. Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science, 1993,261(5120):472-475
35. Masinovsky B, Urdal D, Gallatin WM. IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol, 1990,145(9):2886-2895
36. Dubois GR, Bruijnzeel PL IL-4-induced migration of eosinophils in allergic inflammation. Ann N Y Acad Sci, 1994,725:268-273
37. Hiester AA, Metcalf DR, Campbell PA. Interleukin-4 is chemotactic for mouse macrophages. Cell Immunol, 1992,139(1):72-80
38. Clinchy B, Elenstrom C, Severinson E, et al. T and B cell collaboration: Induction of motility in small, resting B cells by interleukin 4. Eur J Immunol, 1991,21(6):1445-1451
39. Boey H, Rosenbaum R, Castracane J, et al. Interleukin-4 is a neutrophil activator. J Allergy Clin Immunol, 1989,83(5):978-984
40. Lavoie-Lamoureux A, Moran K, Beauchamp G, et al. IL-4 activates equine neutrophils and induces a mixed inflammatory cytokine expression profile with enhanced neutrophil chemotactic mediator release ex vivo. Am J Physiol Lung Cell Mol Physiol, 2010,299(4):L472-L482
41. Mulligan MS, Jones ML, Vaporciyan AA, et al. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol, 1993,151(10):5666-5674
42. Perretti M, Szabo C, Thiemermann C. Effect of inter leukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol, 1995,116(4):2251-2257
43. Piela-Smith TH, Broketa G, Hand A, et al. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J Immunol, 1992,148(5):1375-1381
44. Obiri NI, Tandon N, Puri RK. Up-regulation of intercellular adhesion molecule 1 (ICAM-1) on human renal cell carcinoma cells by interleukin-4. Int J Cancer, 1995,61(5):635-642
45. Valent P, Bevec D, Maurer D, et al. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci USA, 1991,88(8):3339-3342
46. Chinen LT, Cipriano IM, de Oliveira RS, et al. Recombinant interleukin-4-treated macrophages, epithelioid cell surrogates, harbor and arrest mycobacterium avium multiplication in vitro. Microbes Infect, 2006,8(4):965-973
47. Berger RB, Blackwell NM, Lass JH, et al. IL-4 and IL-13 regulation of ICAM-1 expression and eosinophil recruitment in onchocerca volvulus keratitis. Invest Ophthalmol Vis Sci, 2002,43(9):2992-2997
48. Spoelstra FM, Postma DS, Hovenga H, et al. Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts. Eur Respir J, 1999,14(4):759-766
49. Vignola AM, Bonsignore G, Siena L, et al. ICAM-1 and alpha3beta1 expression by bronchial epithelial cells and their in vitro modulation by inflammatory and anti-inflammatory mediators. Allergy, 2000,55(10):931-939
50. Jatakanon A, Uasuf C, Maziak W, et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med, 1999,160(5 Pt 1):1532-1539
51. Yousefi S, Hemmann S, Weber M, et al. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol, 1995,154(10):5481-5490
52. Shannon J, Ernst P, Yamauchi Y, et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest, 2008,133(2):420-426
53. Zerfaoui M, Naura AS, Errami Y, et al. Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: Differential effects on CXCR2 ligands and duffy antigen receptor for chemokines. J Leukoc Biol, 2009,86(6):1385-1392
54. Gjelstrup LC, Boesen T, Kragstrup TW, et al. Shedding of large functionally active CD11/CD18 integrin complexes from leukocyte membranes during synovial inflammation distinguishes three types of arthritis through differential epitope exposure. J Immunol, 2010,185(7):4154-4168
55. Manicone AM. Role of the pulmonary epithelium and inflammatory signals in acute lung injury. Expert Rev Clin Immunol, 2009,5(1):63-75
56. Nathan C. Neutrophils and immunity: Challenges and opportunities. Nat Rev Immunol, 2006,6(3):173-182
57. Yamasawa H, Ishii Y, Kitamura S. Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury. Inflammation, 1999, 23(3):263-274
58. Haddadel B, McCluskie K, Birrell MA, et al. Differential effects of ebselen on neutrophil recruitment, chemokine, and inflammatory mediator expression in a rat model of lipopolysaccharide-induced pulmonary inflammation. J Immunol, 2002,169(2):974-982
59. Zhao M, Brown DM, Maccallum J, et al. Effect of nippostrongylus brasiliensis L3ES on inflammatory mediator gene transcription in lipopolysaccharide lung inflammation. Parasite Immunol, 2009,31(1):50-56
60. Mafra de Lima F, Villaverde AB, Salgado MA, et al. Low intensity laser therapy (LILT) in vivo acts on the neutrophils recruitment and chemokines/cytokines levels in a model of acute pulmonary inflammation induced by aerosol of lipopolysaccharide from escherichia coli in rat. J Photochem Photobiol B, 2010,101(3):271-278
61. Martins JO, Zanoni FL, Martins DO, et al. Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through nuclear factor-kappa B activation in LPS-induced acute lung injury in rats. Shock, 2009,31(4):404-409